Value of Prophylactic Cervical Thymectomy in Parathyroid Hyperplasia

Melissa Boltz, Ning Zhang, Carrie Zhao, Sujan Thiruvengadam, Allan E. Siperstein, Judy Jin

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: In parathyroid hyperplasia (HPT), parathyroid glands within the cervical thymus are a cause for recurrence. As a result of differences in pathophysiology, variable practice patterns exist regarding performing bilateral cervical thymectomy (BCT) in primary hyperplasia versus hyperplasia from renal failure or familial disease. The objective of this study was to capture patients where thymic tissue was found with subtotal parathyroidectomy (PTX) and intended BCT, identify number of thymic supernumerary glands (SNGs), and determine overall cure rate. Methods: Retrospective review of patients with four-gland exploration and intended BCT for HPT from 2000 to 2013 was performed. Identification of thymic tissue and SNGs were determined by operative/pathology reports. Univariate analysis identified differences in cure rate for patients undergoing subtotal PTX with or without BCT. Results: Thymic tissue was found in 52 % of 328 primary HPT (19 % unilateral, 33 % bilateral), 77 % of 128 renal HPT (28 % unilateral, 49 % bilateral), and 100 % of familial HPT (24 % unilateral, 76 % bilateral) patients. Nine percent of primary, 18 % of renal, and 10 % of familial HPT patients had SNGs within thymectomy specimens. Cure rates of primary HPT patients with BCT were 99 % compared to 94 % in subtotal PTX alone. Renal HPT cure rates were 94 % with BCT compared to 89 % without BCT. Conclusions: Renal HPT patients benefited most in cure when thymectomy was performed. Although the rate of SNGs found in primary HPT was lower than renal HPT, the cure rate mimicked the pattern in renal disease. Furthermore, the incidences of SNGs in primary and familial HPT were similar. On the basis of these data, we advocate that BCT be considered in primary HPT when thymic tissue is readily identified.

Original languageEnglish (US)
Pages (from-to)662-668
Number of pages7
JournalAnnals of Surgical Oncology
Volume22
DOIs
StatePublished - Dec 1 2015

Fingerprint

Thymectomy
Hyperplasia
Kidney
Parathyroidectomy
Parathyroid Glands
Thymus Gland
Renal Insufficiency
Pathology
Recurrence

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Boltz, Melissa ; Zhang, Ning ; Zhao, Carrie ; Thiruvengadam, Sujan ; Siperstein, Allan E. ; Jin, Judy. / Value of Prophylactic Cervical Thymectomy in Parathyroid Hyperplasia. In: Annals of Surgical Oncology. 2015 ; Vol. 22. pp. 662-668.
@article{7b520ad398e0445da242736770d46aec,
title = "Value of Prophylactic Cervical Thymectomy in Parathyroid Hyperplasia",
abstract = "Background: In parathyroid hyperplasia (HPT), parathyroid glands within the cervical thymus are a cause for recurrence. As a result of differences in pathophysiology, variable practice patterns exist regarding performing bilateral cervical thymectomy (BCT) in primary hyperplasia versus hyperplasia from renal failure or familial disease. The objective of this study was to capture patients where thymic tissue was found with subtotal parathyroidectomy (PTX) and intended BCT, identify number of thymic supernumerary glands (SNGs), and determine overall cure rate. Methods: Retrospective review of patients with four-gland exploration and intended BCT for HPT from 2000 to 2013 was performed. Identification of thymic tissue and SNGs were determined by operative/pathology reports. Univariate analysis identified differences in cure rate for patients undergoing subtotal PTX with or without BCT. Results: Thymic tissue was found in 52 {\%} of 328 primary HPT (19 {\%} unilateral, 33 {\%} bilateral), 77 {\%} of 128 renal HPT (28 {\%} unilateral, 49 {\%} bilateral), and 100 {\%} of familial HPT (24 {\%} unilateral, 76 {\%} bilateral) patients. Nine percent of primary, 18 {\%} of renal, and 10 {\%} of familial HPT patients had SNGs within thymectomy specimens. Cure rates of primary HPT patients with BCT were 99 {\%} compared to 94 {\%} in subtotal PTX alone. Renal HPT cure rates were 94 {\%} with BCT compared to 89 {\%} without BCT. Conclusions: Renal HPT patients benefited most in cure when thymectomy was performed. Although the rate of SNGs found in primary HPT was lower than renal HPT, the cure rate mimicked the pattern in renal disease. Furthermore, the incidences of SNGs in primary and familial HPT were similar. On the basis of these data, we advocate that BCT be considered in primary HPT when thymic tissue is readily identified.",
author = "Melissa Boltz and Ning Zhang and Carrie Zhao and Sujan Thiruvengadam and Siperstein, {Allan E.} and Judy Jin",
year = "2015",
month = "12",
day = "1",
doi = "10.1245/s10434-015-4859-7",
language = "English (US)",
volume = "22",
pages = "662--668",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",

}

Boltz, M, Zhang, N, Zhao, C, Thiruvengadam, S, Siperstein, AE & Jin, J 2015, 'Value of Prophylactic Cervical Thymectomy in Parathyroid Hyperplasia', Annals of Surgical Oncology, vol. 22, pp. 662-668. https://doi.org/10.1245/s10434-015-4859-7

Value of Prophylactic Cervical Thymectomy in Parathyroid Hyperplasia. / Boltz, Melissa; Zhang, Ning; Zhao, Carrie; Thiruvengadam, Sujan; Siperstein, Allan E.; Jin, Judy.

In: Annals of Surgical Oncology, Vol. 22, 01.12.2015, p. 662-668.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Value of Prophylactic Cervical Thymectomy in Parathyroid Hyperplasia

AU - Boltz, Melissa

AU - Zhang, Ning

AU - Zhao, Carrie

AU - Thiruvengadam, Sujan

AU - Siperstein, Allan E.

AU - Jin, Judy

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Background: In parathyroid hyperplasia (HPT), parathyroid glands within the cervical thymus are a cause for recurrence. As a result of differences in pathophysiology, variable practice patterns exist regarding performing bilateral cervical thymectomy (BCT) in primary hyperplasia versus hyperplasia from renal failure or familial disease. The objective of this study was to capture patients where thymic tissue was found with subtotal parathyroidectomy (PTX) and intended BCT, identify number of thymic supernumerary glands (SNGs), and determine overall cure rate. Methods: Retrospective review of patients with four-gland exploration and intended BCT for HPT from 2000 to 2013 was performed. Identification of thymic tissue and SNGs were determined by operative/pathology reports. Univariate analysis identified differences in cure rate for patients undergoing subtotal PTX with or without BCT. Results: Thymic tissue was found in 52 % of 328 primary HPT (19 % unilateral, 33 % bilateral), 77 % of 128 renal HPT (28 % unilateral, 49 % bilateral), and 100 % of familial HPT (24 % unilateral, 76 % bilateral) patients. Nine percent of primary, 18 % of renal, and 10 % of familial HPT patients had SNGs within thymectomy specimens. Cure rates of primary HPT patients with BCT were 99 % compared to 94 % in subtotal PTX alone. Renal HPT cure rates were 94 % with BCT compared to 89 % without BCT. Conclusions: Renal HPT patients benefited most in cure when thymectomy was performed. Although the rate of SNGs found in primary HPT was lower than renal HPT, the cure rate mimicked the pattern in renal disease. Furthermore, the incidences of SNGs in primary and familial HPT were similar. On the basis of these data, we advocate that BCT be considered in primary HPT when thymic tissue is readily identified.

AB - Background: In parathyroid hyperplasia (HPT), parathyroid glands within the cervical thymus are a cause for recurrence. As a result of differences in pathophysiology, variable practice patterns exist regarding performing bilateral cervical thymectomy (BCT) in primary hyperplasia versus hyperplasia from renal failure or familial disease. The objective of this study was to capture patients where thymic tissue was found with subtotal parathyroidectomy (PTX) and intended BCT, identify number of thymic supernumerary glands (SNGs), and determine overall cure rate. Methods: Retrospective review of patients with four-gland exploration and intended BCT for HPT from 2000 to 2013 was performed. Identification of thymic tissue and SNGs were determined by operative/pathology reports. Univariate analysis identified differences in cure rate for patients undergoing subtotal PTX with or without BCT. Results: Thymic tissue was found in 52 % of 328 primary HPT (19 % unilateral, 33 % bilateral), 77 % of 128 renal HPT (28 % unilateral, 49 % bilateral), and 100 % of familial HPT (24 % unilateral, 76 % bilateral) patients. Nine percent of primary, 18 % of renal, and 10 % of familial HPT patients had SNGs within thymectomy specimens. Cure rates of primary HPT patients with BCT were 99 % compared to 94 % in subtotal PTX alone. Renal HPT cure rates were 94 % with BCT compared to 89 % without BCT. Conclusions: Renal HPT patients benefited most in cure when thymectomy was performed. Although the rate of SNGs found in primary HPT was lower than renal HPT, the cure rate mimicked the pattern in renal disease. Furthermore, the incidences of SNGs in primary and familial HPT were similar. On the basis of these data, we advocate that BCT be considered in primary HPT when thymic tissue is readily identified.

UR - http://www.scopus.com/inward/record.url?scp=84952873225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952873225&partnerID=8YFLogxK

U2 - 10.1245/s10434-015-4859-7

DO - 10.1245/s10434-015-4859-7

M3 - Article

C2 - 26353764

AN - SCOPUS:84952873225

VL - 22

SP - 662

EP - 668

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

ER -